Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences: Amalio Telenti, Brian Rubin, Holden Maecker, and Hamilton Moses

Caris Life Sciences has added four members  Amalio Telenti, Brian Rubin, Holden Maecker, and Hamilton Moses — to its scientific advisory board.

Telenti is chief data scientist and head of computational biology at Vir Biotechnology. He was previously a professor of genomics in the department of integrative structural and computational biology at Scripps Research and chief data scientist for Scripps Research Translational Institute. He also serves on advisory boards for the University of Lausanne's Center for Integrative Genomics, the Institute Pasteur Shanghai at the Chinese Academy of Sciences, and the Swiss Personalized Health Network.

Rubin is chair of the Robert J. Tomsich Pathology & Laboratory Medicine Institute at the Cleveland Clinic, as well as professor of pathology at the Cleveland Clinic Lerner College of Medicine. His research is focused on the diagnosis of soft tissues neoplasms and the analysis of aberrant signal pathways to identify new drug targets and therapeutic resistance mechanisms. 

Maecker is a professor of microbiology and immunology at Stanford University and director of Stanford's Human Immune Monitoring Center, conducting research on T cell response signatures and their association with protection from chronic pathogens and cancer.

Moses is a professor of neurology at the Johns Hopkins School of Medicine, and a life sciences management consultant, working through a company, Alerion Advisors, which he founded in 2002. He has also advised corporations, hospitals, foundations, and governments as a partner and senior advisor with the international strategy firm, The Boston Consulting Group. He previously served as chief physician and chief operating officer of the Johns Hopkins Hospital and Health System, interim chief of psychiatry of the Partners Health Care System and McLean Hospital in Boston, and professor of business at the Darden School of the University of Virginia.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.